Evidence map›Paper›PMID 38348389›Full record

ArticleOncology letters2024

Downregulated expression of PBRM1 in sarcomatoid hepatocellular carcinoma.

Terufumi Yoshida, Kazuko Sakai, Masaki Kaibori, Mitsuaki Ishida, Shogo Tanaka, Shoji Kubo, Takuya Nakai, Marco A De Velasco, Hideyuki Matsushima, Koji Tsuta and 2 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Terufumi YoshidaDepartment of Surgery, Kansai Medical University, Hirakata, Osaka 573-1010, Japan.
Kazuko SakaiDepartment of Genome Biology, Kindai University Faculty of Medicine, Osakasayama, Osaka 589-8511, Japan.
Masaki KaiboriDepartment of Surgery, Kansai Medical University, Hirakata, Osaka 573-1010, Japan.
Mitsuaki IshidaDepartment of Pathology, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka 569-8686, Japan.
Shogo TanakaDepartment of Hepato-Biliary-Pancreatic Surgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Osaka 545-8585, Japan.
Shoji KuboDepartment of Hepato-Biliary-Pancreatic Surgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Osaka 545-8585, Japan.
Takuya NakaiDepartment of Surgery, Kindai University Faculty of Medicine, Osakasayama, Osaka 589-8511, Japan.
Marco A De VelascoDepartment of Genome Biology, Kindai University Faculty of Medicine, Osakasayama, Osaka 589-8511, Japan.
Hideyuki MatsushimaDepartment of Surgery, Kansai Medical University, Hirakata, Osaka 573-1010, Japan.
Koji TsutaDepartment of Pathology, Kansai Medical University, Hirakata, Osaka 573-1010, Japan.
Mitsugu SekimotoDepartment of Surgery, Kansai Medical University, Hirakata, Osaka 573-1010, Japan.
Kazuto NishioDepartment of Genome Biology, Kindai University Faculty of Medicine, Osakasayama, Osaka 589-8511, Japan.
Kansai Medical University · JPKindai University · JPOsaka Metropolitan UniversityOsaka University of Pharmaceutical Sciences · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sarcomatoid hepatocellular carcinoma (SHCC) is a rare and highly lethal subtype of HCC. The present study aimed to explore the unique markers of SHCC using whole gene expression analysis. Subsequently, gene expression analysis was performed using five sarcomatoid and seven carcinomatoid components of seven tissues from patients with SHCC. The results demonstrated a significant downregulation of polybromo 1 (

Indexed as

DNA methylationDNA replicationgene ontologypolybromo 1sarcomatoid hepatocellular carcinoma

Identifiers

PMID38348389
PMCPMC10859838
OpenAlexW4391256689

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.